Clients of Agmon with Tulchinsky Law Firm comment on the ‘excellent service’ they receive from ’great lawyers’. The firm prides itself on its expertise in licensing work, and its recent mandates include high-value deals for some of the country’s largest pharmaceutical companies; it is also adept in matters concerning R&D, regulatory compliance, M&A, IP commercialisation, VC funding, and healthcare litigation. Its clients range from innovative start-ups to multi-national companies. Lead partners Ehud Arad, Osnat Sarusi Firstater, and Uri Barak are recognised experts in corporate and investment matters for hi-tech and life sciences companies. Alon Tabak-Aviram is also recommended for advising leading companies in the pharmaceutical and biotech sectors on corporate and technology licensing matters.
Testimonials
Collated independently by Legal 500 research team.
‘Great team and lawyers.’
‘Excellent service.’
Key clients
- Clalit Healthcare
- Livnat Poran
- Nuversys
- Past and current directors of Teva Pharmaceutical Industries Ltd.
- Shaare Zedek Scientific Ltd.
- Cantor Fitzgerald
- T- Syte
- Virtual Care
- Hospitech Respiration Ltd.
- Lifebiotic Medical research Ltd.
- Phebra Pty Ltd
- Kaizen Bio-Tech
- Enzysurge
- Reuth Rehabilitation Hospital
- Teva Pharmaceutical Industries Ltd.
- Minovia
- Neuroderm
- The National Institute for Biotechnology in the Negev
- Ziv Health care
- CH-Health
- RedHill Biopharma Ltd.
- ConTIPI Medical Ltd.
- Luneau Technology
- Haldor
- Biond Biologics
- RA Capital
- Widex
Work highlights
- Represented Teva in its license of a therapeutic antibody for atopic dermatitis and asthma from Biolojic Design, a biotech company that uses computational biology and artificial intelligence to transform antibodies into intelligent medicinal solutions.
- Represented Kamada, a global pharmaceutical company listed on NASDAQ and TASE, in its licensing and distribution agreements with several significant partners.
- Representing Biond Biologics, a private Israeli immunotherapy company, in several significant agreements that enhance its R&D capabilities, including an agreement with Janssen, valued at tens of millions of USD.
Practice head
The lawyer(s) leading their teams.
Ehud (Udi) Arad, Osnat Sarusi Firstater, Uri Barak